As used in this part, the following definitions apply:

1. (1) "Health care facility" has the meaning provided in 50-5-101.

2. (2) "Health care provider" means any of the following individuals licensed pursuant to Title 37:

   1. (a) a physician;
   2. (b) an advanced practice registered nurse authorized by the board of nursing to prescribe medicine; and
   3. (c) a physician assistant.

3. (3) "Investigational drug, biological product, or device" means a drug, biological product, or device that:

   1. (a) has successfully completed phase 1 of a clinical trial but has not yet been approved for general use by the United States food and drug administration; and
   2. (b) remains under investigation in a United States food and drug administration-approved clinical trial.
4. (4) "Written informed consent" means a written document that meets the requirements of 50-12-105.

History: En. Sec. 2, Ch. 135, L. 2015; amd. Sec. 14, Ch. 88, L. 2023; amd. Sec. 1, Ch. 413, L. 2023.